Abstract | OBJECTIVES: Prior to large studies in breast cancer patients, we have sought to establish the normal range of a potential serum biomarker, Amphiregulin, in healthy women and to determine whether sampling during the menstrual cycle influences the detected Amphiregulin levels. DESIGN AND METHODS: Serum Amphiregulin levels were quantified using a commercially available ELISA in 85 normal female donors. RESULTS: The range of circulating Amphiregulin was 0-4467 pg/mL. The majority of women had no detectable circulating Amphiregulin (n=54), and only five women had levels exceeding 500 pg/mL. Serum Amphiregulin levels did not vary significantly during the menstrual cycle (n=7 women). CONCLUSIONS: Detection of circulating Amphiregulin in a significant minority of healthy women suggests that it may not have the specificity necessary for a population screening tool; however its potential utility for monitoring response to treatment or disease progression should be examined in breast cancer cases.
|
Authors | Esther A Peterson, Shabana Shabbeer, Paraic A Kenny |
Journal | Clinical biochemistry
(Clin Biochem)
Vol. 45
Issue 6
Pg. 460-3
(Apr 2012)
ISSN: 1873-2933 [Electronic] United States |
PMID | 22306169
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- AREG protein, human
- Amphiregulin
- EGF Family of Proteins
- Glycoproteins
- Intercellular Signaling Peptides and Proteins
|
Topics |
- Adult
- Amphiregulin
- EGF Family of Proteins
- Female
- Glycoproteins
(blood)
- Health
- Humans
- Intercellular Signaling Peptides and Proteins
(blood)
- Menstrual Cycle
(blood)
- Middle Aged
- Protein Stability
- Reference Values
- Young Adult
|